sm-7368 and Fibrosarcoma

sm-7368 has been researched along with Fibrosarcoma* in 1 studies

Other Studies

1 other study(ies) available for sm-7368 and Fibrosarcoma

ArticleYear
A small compound that inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-9 upregulation.
    Biochemical and biophysical research communications, 2005, Oct-21, Volume: 336, Issue:2

    Matrix metalloproteinase-9 (MMP-9) is critically involved in the tumor invasion and metastasis processes. Since TNF-alpha plays a crucial role in the regulation of MMP-9 expression, the development of molecules capable of modulating TNF-alpha-induced signaling is an issue of concern. We identified a novel synthetic compound that inhibits TNF-alpha-induced MMP-9 upregulation in the HT1080 human fibrosarcoma cell line. The active compound SM-7368 inhibited TNF-alpha-induced MMP-9 upregulation in a concentration-dependent manner and showed maximal activity at 10 microM. SM-7368 inhibited TNF-alpha-induced MMP-9 mRNA transcript accumulation and protein expression. We also found that SM-7368 strongly inhibits TNF-alpha-induced NF-kappaB activity but not AP-1 activity. Moreover, we found that SM-7368 strongly inhibits the TNF-alpha-induced invasion of HT1080 human fibrosarcoma cell line. Taken together, our results demonstrate that SM-7368 is a synthetic compound that inhibits TNF-alpha-induced MMP-9 expression, and thus SM-7368 should be useful for the development of chemotherapies targeting TNF-alpha-mediated tumor invasion and metastasis.

    Topics: Benzamides; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Fibrosarcoma; Humans; Matrix Metalloproteinase 9; Molecular Weight; NF-kappa B; Thiazoles; Tumor Necrosis Factor-alpha; Up-Regulation

2005